Stratec Biomedical AG STRATEC BIOMEDICAL ORD SHS
Stratec Biomedical AG STRATEC BIO.../ DE000STRA555 /
0RAR
|
11/15/2024 5:00:12 PM
|
Chg.
+0.60
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
29.50EUR
|
+2.08%
|
58
Turnover: 1,726.15 |
-Bid Size: - |
-Ask Size: - |
353.74 mill.EUR |
1.89% |
27.20 |
Business description
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
Management board & Supervisory board
| CEO |
| Marcus Wolfinger |
| Management board |
| Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer |
| Supervisory board |
| Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller |
Company data
| Name: |
STRATEC SE |
| Address: |
Gewerbestraße 37,D-75217 Birkenfeld |
| Phone: |
+49-7082-7916-0 |
| Fax: |
+49-7082-7916-999 |
| E-mail: |
info@stratec.com
|
| Internet: |
www.stratec.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
35.57% |
| IPO date: |
8/25/1998 |
Investor relations
| Name: |
Jan Keppeler |
| IR phone: |
+49-7082-7916-991 |
| IR Fax: |
+49-7082-7916-9190 |
| IR e-mail: |
ir@stratec.com
|
